Michael E. Nassif
机构:Saint Luke's Health System, Temple College, Saint Luke's Hospital · ORCID:0000-0002-1232-7604
发表论文 206 篇 · 总被引 6699 次 · h-index 38
代表论文
- Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy (2025 · New England Journal of Medicine · 被引 61)
- Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy (2025 · JACC Heart Failure · 被引 21)
- Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial (2025 · European Heart Journal · 被引 11)
- Low incidence of atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with aficamten: An analysis from the REDWOOD-HCM, SEQUOIA-HCM, and FOREST-HCM trials (2025 · Heart Rhythm · 被引 4)
- Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy (2025 · Journal of the American College of Cardiology · 被引 4)
- Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure (2026 · JACC Heart Failure · 被引 2)